Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

Research Site, Liverpool

Research Site, East Melbourne

Research Site, New York

Research Site, Berlin

Research Site, Rochester

Research Site, Norfolk

Research Site, Charleston

Research Site, Hanover

Research Site, Miami

Research Site, Clearwater

Research Site, Wuppertal

Research Site, Bochum

Research Site, Warren

Research Site, Münster

Research Site, Dülmen

Research Site, Frankfurt am Main

Research Site, Stuttgart-Weilimdorf

Research Site, Rogers

Research Site, Houston

Research Site, Houston

Research Site, San Antonio

Research Site, San Antonio

Research Site, Pflugerville

Research Site, München

Research Site, Phoenix

Research Site, Los Angeles

Research Site, Santa Monica

Research Site, Oceanside

Research Site, Rancho Santa Margarita

Research Site, Fullerton

Research Site, Fremont

Research Site, Portland

Research Site, Worcester

Research Site, Berlin

Research Site, Verona

Research Site, Kogarah

Research Site, Sydney

Research Site, Woolloongabba

Research Site, Surrey

Research Site, Courtice

Research Site, Markham

Research Site, Peterborough

Research Site, Waterloo

Research Site, Windsor

Research Site, Dresden

Research Site, Nakano

Research Site, Shibuya-ku

Research Site, Shinjuku-ku

Research Site, Shinjuku-ku

Research Site, Shinjuku-ku

Research Site, Yokohama

Research Site, Katowice

Research Site, Lodz

Research Site, Szczecin

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Wroclaw